EZH2 and cancer: Enhancer of Zeste Homolog 2 (EZH2), the core catalytic component of the polycomb repressive complex 2 (PRC2), also affects cancer progression by altering histone H3lysine27 (H3K27) trimethylation and silencing transcription [15].